MAGNESIUM OXIDE- magnesium oxide tablet
PAR Pharmaceuticals

----------

306-Magnesium Oxide 420mg

Active ingredient(s)

Magnesium Oxide

Purpose

Magnesium Oxide may help in magnesium deficiencies †

Use(s)

As a dietary supplement.

Warnings

Do not use

Do not take this product if you are presently taking a prescription drug without consulting your physician or other health care professional. If you have kidney disease, take only under the supervision of a physician. May have a laxative effect.

Pregnancy/Breastfeeding

ask a health professional before use.

Keep out of reach of children

Directions

Take one tablet daily or as directed by a physician.

Other information

This product is sealed for your protection. Do not use if imprinted safety seal under cap is broken or missing.

Storage

Keep tightly closed and store in a cool, dry place.

Inactive ingredients

colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, stearic acid.

Principal Display Panel

Magnesium Oxide

†These statements have not been evaluated by The Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure or prevent any disease. Manufactured for: Qualitest Pharmaceuticals 130 Vintage Drive Huntsville, AL 35811 USA

MAGNESIUM OXIDE
magnesium oxide tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:0603-0213
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838)	MAGNESIUM OXIDE	253 mg

Ingredient Name	Strength
Inactive Ingredients
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
STEARIC ACID (UNII: 4ELV7Z65AP)

Product Characteristics
Color	white	Score	no score
Shape	ROUND	Size	11mm
Flavor		Imprint Code	306
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:0603-0213-21	100 in 1 BOTTLE; Type 0: Not a Combination Product	11/10/2020

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M001	11/10/2020

Labeler - PAR Pharmaceuticals (092733690)

Name	Address	ID/FEI	Business Operations
Establishment
Allegiant Health		079501930	analysis(0603-0213) , label(0603-0213) , manufacture(0603-0213) , pack(0603-0213)

Revised: 11/2020

Document Id: b40d866b-76d8-4522-bf1b-0ad137cedb42

Set id: d5c123f8-1396-4d8c-96d3-e5ade96a6ef8

Version: 12

Effective Time: 20201110

PAR Pharmaceuticals